About Spectrix Therapeutics
Spectrix Therapeutics, LLC is a privately-held specialty pharmaceutical company committed to transforming how disorders, such as hypothyroidism, are treated pharmacologically. Our therapies will redefine how patients cope with those disorders and improve quality of life.Know More
Our technologies utilize ion exchange resin to form a drug resin complex. The drug is first dissolved in a solution removing variability due to crystalline structure.
Spectrix clinical studies will be based on 505(b)(2) NDA regulatory pathway leveraging prior clinical data to greatly reduce time and cost.
Spectrix will attend the 2018 BIO International Convention in Boston this June. To schedule a meeting with Spectrix during this conference, please contact Sara Rice at firstname.lastname@example.org